- The 8 States Most Likely to Legalize Marijuana Next
- Behind Russia's Current Crisis: It's Not the Ruble, It's Putin
- Would you invest in the U.S. Postal Service?
- Why Jim Cramer Says it Could be Too Late to Enter the Stock Market Rally Now
- Apple (AAPL) Stock Declining Today Amid Allegations of Poor Working Conditions in China
After decades of broken promises, RadioShack seems close to the end.
Ciena's struggles have more to do with industry trends and weak enterprise spending and less to do with its own operational problems.
The sector has performed well this year. The question is, will it last?
In 2014 drugmakers long on cash but short on growth bought quick access to markets that would have otherwise taken years to build. Can this continue?
The stock is up more than 50% so far this year, but that doesn't mean it's necessarily time to sell.
Campbell's strong yield of 2.80% makes it a solid defensive play in a market that is always waiting for a pullback.
The best play here is to add to an existing long position and wait for Merck to execute on its value-creation plans.
A new CEO is ready to battle Starbucks and Dunkin for the coffee and doughnuts trade.
Investors should lock in their gains now and wait for clearer signs that the company has turned the corner.
With the disappointing news already out of the way, now's the time to buy, especially since Smucker is buying as well.